Tag: isavuconazole

December 21, 2021 Off

Pfizer get China approval for antifungal Cresemba

Basilea Pharmaceutica’s license partner, Pfizer, has received a Drug Approval License from the National Medical Products Administration (NMPA) in China, for the oral formulation of its antifungal Cresemba® (isavuconazole).

February 8, 2019 Off

Basilea nets milestone payment from Pfizer for Cresemba sales in Europe

By Dino Mustafić

Basilea Pharmaceutica cahsed $5 million from Pfizer’s milestone payment triggered for selling of the antifungal Cresemba in Europe..